AU2002227279A1 - Polynucleotide and polypeptide sequences of putative transporters and ion channells - Google Patents

Polynucleotide and polypeptide sequences of putative transporters and ion channells

Info

Publication number
AU2002227279A1
AU2002227279A1 AU2002227279A AU2727902A AU2002227279A1 AU 2002227279 A1 AU2002227279 A1 AU 2002227279A1 AU 2002227279 A AU2002227279 A AU 2002227279A AU 2727902 A AU2727902 A AU 2727902A AU 2002227279 A1 AU2002227279 A1 AU 2002227279A1
Authority
AU
Australia
Prior art keywords
channells
polynucleotide
ion
polypeptide sequences
putative transporters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227279A
Inventor
Chandra Arvizu
Yalda Azimzai
Maria R. Baughn
Christopher M. Bruns
Neil Burford
Narinder K. Chawla
Li Ding
Brendan M. Duggan
Vicki S. Elliott
Ameena R. Gandhi
April J. A. Hafalia
Craig H. Ison
Farrah A. Khan
Preeti G. Lal
Ernestine A. Lee
Dyung Aina M. Lu
Yan Lu
Dannie B. Nguyen
Jennifer L. Policky
Jayalaxmi Ramkumar
Brigitte E. Raumann
Anita Swarnakar
Y. Tom Tang
Kavitha Thangavelu
Michael Thornton
Catherine M. Tribouley
Bridget A. Warren
Yuming Xu
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002227279A1 publication Critical patent/AU2002227279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002227279A 2000-12-08 2001-12-05 Polynucleotide and polypeptide sequences of putative transporters and ion channells Abandoned AU2002227279A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US25430300P 2000-12-08 2000-12-08
US60/254,303 2000-12-08
US25619000P 2000-12-15 2000-12-15
US60/256,190 2000-12-15
US25750400P 2000-12-21 2000-12-21
US60/257,504 2000-12-21
US26154601P 2001-01-12 2001-01-12
US60/261,546 2001-01-12
US26283201P 2001-01-19 2001-01-19
US60/262,832 2001-01-19
US26437701P 2001-01-26 2001-01-26
US60/264,377 2001-01-26
US26601901P 2001-02-02 2001-02-02
US60/266,019 2001-02-02
PCT/US2001/046963 WO2002046415A2 (en) 2000-12-08 2001-12-05 Polynucleotide and polypeptide sequences of putative transporters and ion channells

Publications (1)

Publication Number Publication Date
AU2002227279A1 true AU2002227279A1 (en) 2002-06-18

Family

ID=27569477

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002227279A Abandoned AU2002227279A1 (en) 2000-12-08 2001-12-05 Polynucleotide and polypeptide sequences of putative transporters and ion channells

Country Status (2)

Country Link
AU (1) AU2002227279A1 (en)
WO (1) WO2002046415A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002227929A1 (en) * 2000-11-17 2002-05-27 Bayer Aktiengesellschaft Regulation of human nmda receptor
AU2002243633A1 (en) * 2001-01-23 2002-08-06 Lexicon Genetics Incorporated Human ion exchanger proteins and polynucleotides encoding the same
WO2002063002A2 (en) * 2001-02-02 2002-08-15 Lexicon Genetics Incorporated Novel human transporter protein and polynucleotides encoding the same
EP1383791A4 (en) * 2001-03-30 2005-06-08 Applera Corp Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20030049664A1 (en) * 2001-07-17 2003-03-13 Millennium Pharmaceuticals, Inc. 87144, human amino acid transporter family member and uses therefor
AU2002326497A1 (en) * 2001-08-02 2003-02-17 Bristol-Myers Squibb Company Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
US7504481B2 (en) 2001-08-02 2009-03-17 Bristol-Meyers Squibb Company TRP channel family member, LTRPC3 polypeptides
WO2003016478A2 (en) * 2001-08-20 2003-02-27 Bristol-Myers Squibb Company G-protein coupled receptor polynucleotides and methods of use thereof
EP1430144A4 (en) * 2001-09-28 2006-02-01 Millennium Pharm Inc METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
FR2837492B1 (en) * 2002-03-21 2007-07-20 Commissariat Energie Atomique APICAL IODE TRANSPORTER AND ITS APPLICATIONS
WO2003104427A2 (en) * 2002-06-05 2003-12-18 Case Western Reserve University Methods and compositions for detecting cancers
US7476508B2 (en) 2003-01-17 2009-01-13 Astellas Pharma Inc. Method of screening agent for improving memory and learning ability
US7344882B2 (en) 2003-05-12 2008-03-18 Bristol-Myers Squibb Company Polynucleotides encoding variants of the TRP channel family member, LTRPC3
US7723019B2 (en) * 2003-05-20 2010-05-25 University Of Kentucky Research Foundation Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof
WO2005015204A2 (en) * 2003-08-06 2005-02-17 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with organic anion transporter ust3 like 3 (ust3 like 3)
US20070037204A1 (en) 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
EP2311468B1 (en) * 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gene overexpressed in cancer

Also Published As

Publication number Publication date
WO2002046415A9 (en) 2002-09-06
WO2002046415A3 (en) 2003-08-14
WO2002046415A2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
IL153970A0 (en) Promyostatin peptides and methods of using same
AU2002227279A1 (en) Polynucleotide and polypeptide sequences of putative transporters and ion channells
AU2001286730A1 (en) An iap binding peptide or polypeptide and methods of using the same
AU2484399A (en) Controlled release delivery of peptide or protein
AU2002225247A1 (en) The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001244286A1 (en) Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof
GB9918155D0 (en) Proteins and peptides
GB0026134D0 (en) Peptides and their use
GB0217327D0 (en) Peptide fragments of colostrinin and their use
EP1144629A3 (en) Further pro polypeptides and sequences thereof
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
AU2001245367A1 (en) Human transporter genes and proteins encoded thereby
AU5495500A (en) Decorin binding protein essential peptides and methods of use
AU1798100A (en) Use of peptide
AU2001277750A1 (en) Use of polypeptide
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU2001275337A1 (en) Novel human transporter proteins and polynucleotides encoding the same
AU4328500A (en) Retro-inverso prosaposin-derived peptides and use thereof
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same
AU6744400A (en) Peptides consisting of fragments of gli-1 and sufuh and their use
AU1415301A (en) Use of peptide
AU2001270794A1 (en) Short peptides comprising histidine or alanine and their therapeutic use
AU2001247283A1 (en) Human transporter proteins and polynucleotides encoding the same